arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Agios Pharmaceuticals, Inc.

AGIO Health Care Biotechnology: Pharmaceutical Preparations
$28.29
▼ -1.7% Today
as of Jun 7, 07:08 ET
Last 30 days +14.07% Apr 28 → Jun 05
$24.35 $25.98 $27.61 $29.24 $30.87 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$28.95
High
$29.39
Low
$28.13
Volume
$561,244
Avg Vol
$1M
Mkt Cap
$1.8B
P/E (TTM)
Beta
52w High
$46.00
52w Low
$22.24
Div Yield
Shares Out
$59M

Overview

52-week range
$22
$46
25% of range
Avg surprise (last 1)
+13.9%
Avg reaction (last 1)
+4.2%
100% positive
Latest IV / EM
76%
EM ±10.5% · $30 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.93$2.61$7.14$11.68$16.22 Actual $-1.51Actual $-1.64Actual $-1.45Actual $-1.69Actual $16.22Actual $-1.55Est $-1.80Actual $-1.93Actual $-1.78Actual $-1.69 JunSepMarJunSepMar/2025JunSepMar
Revenue vs Net Income Revenue Net income
$-112M$165M$442M$718M$995M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Mar 31, 2026Mar 2026 $-1.69 financials
Tue Sep 30, 2025Sep 2025 $-1.78 financials
Mon Jun 30, 2025Jun 2025 $-1.93 financials
Thu May 1, 2025Mar/2025 $-1.55 $-1.80 +13.9% +4.2% earnings
Mon Sep 30, 2024Sep 2024 $16.22 financials
Sun Jun 30, 2024Jun 2024 $-1.69 financials
Sun Mar 31, 2024Mar 2024 $-1.45 financials
Sat Sep 30, 2023Sep 2023 $-1.64 financials
Fri Jun 30, 2023Jun 2023 $-1.51 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$1M$2M$2M$1M$783,000$1M
Gross profit
Operating income$-110M$-117M$-127M$-107M$-103M$-106M
Net income$-99M$-103M$-112M$-89M$948M$-96M
EPS (diluted)$-1.69$-1.78$-1.93$-1.55$16.22$-1.69

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$114M$89M$93M$81M$79M$76M$254M$85M
Inventory$35M$33M$32M$31M$30M$28M$26M$24M
Total current assets$835M$942M$1.03B$1.02B$969M$966M$1.07B$632M
Total assets$1.18B$1.30B$1.39B$1.47B$1.56B$1.66B$1.79B$773M
Long-term debt
Total liabilities$76M$104M$101M$102M$89M$122M$165M$113M
Total equity$1.11B$1.19B$1.28B$1.37B$1.47B$1.54B$1.63B$661M

Implied volatility — last 90 days

70%73%75%78%80% Jun 07 — IV 76% · EM ±10.5%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.